new semaglutide pill Wegovy® Type 2 diabetes: New Ozempic

Life Sci., 54: 1316-1329 Cordido et al (1993), Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity

Bass Weekly Medication & Supplies Monthly Styku 360 Body Analysis Monthly Vitamin Injection Preferred Member Pricing: Savings on Botox & Fillers Enhanced results with Tirzepatide available for $575/mo

You'll likely see it combined with Sorbitan Olivate (together sold as the trade name Olivem 1000)

Once submitted, the FDA has 60 days to accept the application and assign a PDUFA date, after which the 610 month review period begins

Eli Lilly is developing an oral tirzepatide formulation, but this is still in clinical trials and not yet available

PMID: 35557581